Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01342133 · ClinicalTrials.gov registry record
Sweat Duct Imaging in Mother/Newborn Dyads
A clinical trial of X-Linked Hypohidrotic Ectodermal Dysplasia, sponsored by Edimer Pharmaceuticals.
- Completed
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT01342133: Completed study of X-Linked Hypohidrotic Ectodermal Dysplasia, sponsored by Edimer Pharmaceuticals.
NCT01342133 is a study of X-Linked Hypohidrotic Ectodermal Dysplasia that has completed, run by Edimer Pharmaceuticals. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01342133, a study of X-Linked Hypohidrotic Ectodermal Dysplasia, has completed, sponsored by Edimer Pharmaceuticals.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate sweat duct number on the plantar surface of newborn infants using a non-invasive confocal microscopy device.
Primary Outcome
To demonstrate the ease of use of a non-invasive confocal imaging device in the evaluation and measurement of sweat ducts on the plantar surface of healthy, term newborns. These measurements will be used as comparison data in subsequent trials involving those affected by X-Linked Hypohidrotic Ectodermal Dysplasia.
Conditions Studied
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-07 |
What the finished NCT01342133 record still lists
NCT01342133 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 1 condition, with X-Linked Hypohidrotic Ectodermal Dysplasia appearing as the primary indexed condition, and to 0 interventions.
NCT01342133 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT01342133 about?
NCT01342133 is a clinical study titled "Sweat Duct Imaging in Mother/Newborn Dyads". The purpose of this study is to evaluate sweat duct number on the plantar surface of newborn infants using a non-invasive confocal microscopy device.
What is the current status of trial NCT01342133?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2011-04. Estimated completion is 2011-07.
What conditions does trial NCT01342133 study?
This clinical trial studies the following conditions: X-Linked Hypohidrotic Ectodermal Dysplasia.
Who is sponsoring clinical trial NCT01342133?
This trial is sponsored by Edimer Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01342133 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia